Variant CJD: 18 years of research and surveillance

Prion

Volumn 8, Issue 4, 2014, Pages 286-295

  Diack, Abigail B ^a   Head, Mark W ^b   McCutcheon, Sandra ^a   Boyle, Aileen ^a   Knight, Richard ^b   Ironside, James W ^b   Manson, Jean C ^a   Will, Robert G ^b  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Prion; Prion protein; Transmissible spongiform encephalopathy; Variant Creutzfeldt Jakob disease

Indexed keywords

DOXYCYCLINE; MEPACRINE; PENTOSAN POLYSULFATE; PRION PROTEIN; CODON; PRION;

ARTICLE; BLOOD TRANSFUSION; BOVINE SPONGIFORM ENCEPHALOPATHY; CODON; CREUTZFELDT JAKOB DISEASE; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; MEDICAL RESEARCH; NONHUMAN; PREVALENCE; UNITED KINGDOM; ADVERSE EFFECTS; ANIMAL; BRAIN; CREUTZFELDT-JAKOB SYNDROME; GENETIC POLYMORPHISM; GENETICS; GREAT BRITAIN; METABOLISM; PATHOLOGY; PRION; RISK FACTOR; TRANSMISSION;

MUS; MUS MUSCULUS; OVIS ARIES;

ANIMALS; BLOOD TRANSFUSION; BRAIN; CODON; CREUTZFELDT-JAKOB SYNDROME; GENOTYPE; GREAT BRITAIN; HUMANS; POLYMORPHISM, GENETIC; PRIONS; RISK FACTORS;

EID: 84919767337     PISSN: 19336896     EISSN: 1933690X     Source Type: Journal    
DOI: 10.4161/pri.29237     Document Type: Article

References (118)

1. Wells GA, Scott AC, Johnson CT, Gunning RF, Hancock RD, Jeffrey M, Dawson M., Bradley R. A novel progressive spongiform encephalopathy in cattle. Vet Rec 1987; 121:419-20; PMID:3424605; http://dx.doi.org/10.1136/vr.121.18.419
2. Fraser H, Bruce ME, Chree A, McConnell I., Wells GA Transmission of bovine spongiform encephalopathy and scrapie to mice. J Gen Virol 1992; 73:1891-7; PMID:1645134; http://dx.doi.org/10.1099/0022-1317-73-8-1891
3. Fraser H, Pearson GR, McConnell I, Bruce ME, Wyatt JM, Gruffydd-Jones TJ. Transmission of feline spongiform encephalopathy to mice. Vet Rec 1994; 134:449; PMID:8048218; http://dx.doi.org/10.1136/vr.134.17.449
4. Bruce M, Chree A, McConnell I., Foster J, Pearson G, Fraser H. Transmission of bovine spongiform encephalopathy and scrapie to mice: strain variation and the species barrier. Philos Trans R Soc Lond B Biol Sci 1994; 343:405-11; PMID:7913758; http://dx.doi.org/10.1098/rstb.1994.0036
5. Foster JD, Hope J, Fraser H. Transmission of bovine spongiform encephalopathy to sheep and goats. Vet Rec. 1993;133:339-41. PMID:8236676
6. Will RG, Ironside JW, Zeidler M, Cousens SN, Estibeiro K., Alperovitch A, Poser S, Pocchiari M., Hofman A, Smith PG A new variant of CreutzfeldtJakob disease in the UK. Lancet 1996; 347:921-5; PMID:8598754; http://dx.doi.org/10.1016/S0140-6736(96)91412-9
7. Ward HJ, Everington D, Cousens SN, Smith-Bathgate B, Leitch M, Cooper S., Heath C, Knight RS, Smith PG, Will RG. Risk factors for variant Creutzfeldt-Jakob disease: a case-control study. Ann Neurol 2006; 59:111-20; PMID:16287153; http://dx.doi.org/10.1002/ana.20708
8. Bruce ME, Will RG, Ironside JW, McConnell I., Drummond D, Suttie A, McCardle L., Chree A, Hope J, Birkett C., et al. Transmissions to mice indicate that 'new variant' CJD is caused by the BSE agent. Nature 1997; 389:498-501; PMID:9333239; http://dx.doi.org/10.1038/39057
9. Hill AF, Desbruslais M, Joiner S., Sidle KC, Gowland I, Collinge J, Doey LJ, Lantos P. The same prion strain causes vCJD and BSE. Nature 1997; 389:448-50, 526; PMID:9333232; http://dx.doi.org/10.1038/38925
10. Brown DA, Bruce ME, Fraser JR Comparison of the neuropathological characteristics of bovine spongiform encephalopathy (BSE) and variant CreutzfeldtJakob disease (vCJD) in mice. Neuropathol Appl Neurobiol 2003; 29:262-72; PMID:12787323; http://dx.doi.org/10.1046/j.1365-2990.2003.00462.x
11. Bruce ME. TSE strain variation. Br Med Bull 2003; 66:99-108; PMID:14522852; http://dx.doi.org/10.1093/bmb/66.1.99
12. Ritchie DL, Boyle A, McConnell I., Head MW, Ironside JW, Bruce ME Transmissions of variant Creutzfeldt-Jakob disease from brain and lymphoreticular tissue show uniform and conserved bovine spongiform encephalopathy-related phenotypic properties on primary and secondary passage in wildtype mice. J Gen Virol 2009; 90:3075-82; PMID:19656962; http://dx.doi.org/10.1099/vir.0.013227-0
13. Stack MJ, Chaplin MJ, Clark J. Differentiation of prion protein glycoforms from naturally occurring sheep scrapie, sheep-passaged scrapie strains (CH1641 and SSBP1), bovine spongiform encephalopathy (BSE) cases and Romney and Cheviot breed sheep experimentally inoculated with BSE using two monoclonal antibodies. Acta Neuropathol 2002; 104:279-86; PMID:12172914
14. Collinge J, Sidle KC, Meads J, Ironside J., Hill AF Molecular analysis of prion strain variation and the aetiology of 'new variant' CJD. Nature 1996; 383:685-90; PMID:8878476; http://dx.doi.org/10.1038/383685a0
15. Head MW, Bunn TJR, Bishop MT, McLoughlin V, Lowrie S., McKimmie CS, Williams MC, McCardle L, MacKenzie J., Knight R, et al. Prion protein heterogeneity in sporadic but not variant Creutzfeldt-Jakob disease: UK cases 1991-2002. Ann Neurol 2004; 55:851-9; PMID:15174020; http://dx.doi.org/10.1002/ana.20127
16. Head MW, Ritchie D, Smith N., McLoughlin V, Nailon W, Samad S., Masson S, Bishop M, McCardle L., Ironside JW. Peripheral tissue involvement in sporadic, iatrogenic, and variant Creutzfeldt-Jakob disease: an immunohistochemical, quantitative, and biochemical study. Am J Pathol 2004; 164:143-53; PMID:14695328; http://dx.doi.org/10.1016/S0002-9440(10)63105-7
17. Head MW, Yull HM, Ritchie DL, Bishop MT, Ironside JW Pathological investigation of the first blood donor and recipient pair linked by transfusion-associated variant Creutzfeldt-Jakob disease transmission. Neuropathol Appl Neurobiol 2009; 35:433-6; PMID:19490428; http://dx.doi.org/10.1111/j.1365-2990.2009.01025.x
18. Peden A, McCardle L, Head MW, Love S., Ward HJT, Cousens SN, Keeling DM, Millar CM, Hill FGH, Ironside JW Variant CJD infection in the spleen of a neurologically asymptomatic UK adult patient with haemophilia. Haemophilia 2010; 16:296-304; PMID:20070383; http://dx.doi.org/10.1111/j.1365-2516.2009.02181.x
19. Peden AH, Head MW, Ritchie DL, Bell JE, Ironside JW Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient. Lancet 2004; 364:527-9; PMID:15302196; http://dx.doi.org/10.1016/S0140-6736(04)16811-6
20. Bishop MT, Hart P, Aitchison L., Baybutt HN, Plinston C, Thomson V, Tuzi NL, Head MW, Ironside JW, Will RG, et al Predicting susceptibility and incubation time of human-to-human transmission of vCJD. Lancet Neurol 2006; 5:393-8; PMID: 16632309; http://dx.doi.org/10.1016/S1474-4422(06)70413-6
21. Jones M, Wight D, Barron R., Jeffrey M, Manson J, Prowse C., Ironside JW, Head MW Molecular model of prion transmission to humans. Emerg Infect Dis 2009; 15:2013-6; PMID:19961689; http://dx.doi.org/10.3201/eid1512.090194
22. Parchi P, Notari S, Weber P., Schimmel H, Budka H, Ferrer I., Haik S, Hauw JJ, Head MW, Ironside JW, et al. Inter-laboratory assessment of PrPSc typing in creutzfeldt-jakob disease: a Western blot study within the NeuroPrion Consortium. Brain Pathol 2009; 19:384-91; PMID:18624793; http://dx.doi.org/10.1111/j.1750-3639.2008.00187.x
23. Choi YP, Groner A, Ironside JW, Head MW Comparison of the level, distribution and form of disease-associated prion protein in variant and sporadic Creutzfeldt-Jakob diseased brain using conformation-dependent immunoassay and Western blot. J Gen Virol 2011; 92:727-32; PMID:21123539; http://dx.doi.org/10.1099/vir.0.026948-0
24. Yull HM, Ritchie DL, Langeveld JP, van Zijderveld FG, Bruce ME, Ironside JW, Head MW Detection of type 1 prion protein in variant Creutzfeldt-Jakob disease. Am J Pathol 2006; 168:151-7; PMID: 16400018; http://dx.doi.org/10.2353/ajpath.2006.050766
25. Choi YP, Groner A, Ironside JW, Head MW Correlation of polydispersed prion protein and characteristic pathology in the thalamus in variant Creutzfeldt-Jakob disease: implication of small oligomeric species. Brain Pathol 2011; 21:298-307; PMID:21029243; http://dx.doi.org/10.1111/j.1750-3639.2010.00446.x
26. Choi YP, Peden AH, Groner A, Ironside JW, Head MW Distinct stability states of disease-associated human prion protein identified by conformation-dependent immunoassay. J Virol 2010; 84:12030-8; PMID:20844046; http://dx.doi.org/10.1128/JVI.01057-10
27. National CJD Research & Surveillance Unit Data and Reports. Latest NCJDSRU CJD Monthly Statistics. [cited 2014 April]. Available from: http://www.cjd.ed.ac.uk/documents/figs.pdf
28. Chadeau-Hyam M., Alperovitch A Risk of variant Creutzfeldt-Jakob disease in France. Int J Epidemiol 2005; 34:46-52; PMID:15649960; http://dx.doi.org/10.1093/ije/dyh374
29. Brandel JP, Peckeu L, Haïk S. The French surveillance network of Creutzfeldt-Jakob disease. Epidemiological data in France and worldwide. Transfus Clin Biol 2013; 20:395-7; PMID:23587616; http://dx.doi.org/10.1016/j.tracli.2013.02.029
30. Brandel JP, Heath CA, Head MW, Levavasseur E., Knight R, Laplanche JL, Langeveld JP, Ironside JW, Hauw JJ, Mackenzie J, et al Variant Creutzfeldt-Jakob disease in France and the United Kingdom: Evidence for the same agent strain. Ann Neurol 2009; 65:249-56; PMID:19334063; http://dx.doi.org/10.1002/ana.21583
31. Sanchez-Juan P., Cousens SN, Will RG, van Duijn CM. Source of variant Creutzfeldt-Jakob disease outside United Kingdom. Emerg Infect Dis 2007; 13:1166-9; PMID:17953086; http://dx.doi.org/10.3201/eid1308.070178
32. Diack AB, Ritchie D, Bishop M, Pinion V, Brandel JP, Haik S, Tagliavini F, Van Duijn C, Belay ED, Gambetti P, et al. Constant transmission properties of variant Creutzfeldt-Jakob disease in 5 countries. Emerg Infect Dis 2012; 18:1574-9; PMID:23017202; http://dx.doi.org/10.3201/eid1810.120792
33. Pocchiari M, Puopolo M, Croes EA, Budka H., Gelpi E, Collins S, Lewis V., Sutcliffe T, Guilivi A, Delasnerie-Laupretre N, et al. Predictors of survival in sporadic Creutzfeldt-Jakob disease and other human transmissible spongiform encephalopathies. Brain 2004; 127:2348-59; PMID:15361416; http://dx.doi.org/10.1093/brain/awh249
34. Lee HS, Brown P, Cervenakovâ L, Garruto RM, Alpers MP, Gajdusek DC, Goldfarb LG. Increased susceptibility to Kuru of carriers of the PRNP 129 methionine/methionine genotype. J Infect Dis 2001; 183:192-6; PMID:11120925; http://dx.doi.org/10.1086/317935
35. Nurmi MH, Bishop M, Strain L., Brett F, McGuigan C, Hutchison M., Farrell M, Tilvis R, Erkkilä S, Simell O, et al. The normal population distribution of PRNP codon 129 polymorphism. Acta Neurol Scand 2003; 108:374-8; PMID:14616310; http://dx.doi.org/10.1034/j.1600-0404.2003.00199.x
36. Asante EA, Linehan JM, Desbruslais M, Joiner S., Gowland I, Wood AL, Welch J, Hill AF, Lloyd SE, Wadsworth JD, et al BSE prions propagate as either variant CJD-like or sporadic CJD-like prion strains in transgenic mice expressing human prion protein. EMBO J 2002; 21:6358-66; PMID:12456643; http://dx.doi.org/10.1093/emboj/cdf653
37. Bishop MT, Diack AB, Ritchie DL, Ironside JW, Will RG, Manson JC. Prion infectivity in the spleen of a PRNP heterozygous individual with subclinical variant Creutzfeldt-Jakob disease. Brain 2013; 136:1139-45; PMID:23449776; http://dx.doi.org/10.1093/brain/awt032
38. Kaski D, Mead S, Hyare H., Cooper S, Jampana R, Overell J., Knight R, Collinge J, Rudge P. Variant CJD in an individual heterozygous for PRNP codon 129. Lancet 2009; 374:2128; PMID:20109837; http://dx.doi.org/10.1016/S0140-6736(09)61568-3
39. Gill ON, Spencer Y, Richard-Loendt A, Kelly C., Dabaghian R, Boyes L, Linehan J., Simmons M, Webb P, Bellerby P., et al. Prevalent abnormal prion protein in human appendixes after bovine spongiform encephalopathy epizootic: large scale survey. BMJ 2013; 347:f5675; PMID:24129059; http://dx.doi.org/10.1136/bmj.f5675
40. Ironside JW, Bishop MT, Connolly K, Hegazy D., Lowrie S, Le Grice M, Ritchie DL, McCardle LM, Hilton DA Variant Creutzfeldt-Jakob disease: prion protein genotype analysis of positive appendix tissue samples from a retrospective prevalence study. BMJ 2006; 332:1186-8; PMID: 16606639; http://dx.doi.org/10.1136/bmj.38804.511644.55
41. Hewitt PE, Llewelyn CA, Mackenzie J, Will RG Creutzfeldt-Jakob disease and blood transfusion: results of the UK Transfusion Medicine Epidemiological Review study. Vox Sang 2006; 91:221-30; PMID: 16958834; http://dx.doi.org/10.1111/j.1423-0410.2006.00833.x
42. Bons N, Lehmann S, Mestre-Frances N, Dormont D., Brown P. Brain and buffy coat transmission of bovine spongiform encephalopathy to the primate Microcebus murinus. Transfusion 2002; 42:513-6; PMID: 12084158; http://dx.doi.org/10.1046/j.1537-2995.2002.00098.x
43. Brown P, Rohwer RG, Dunstan BC, MacAuley C., Gajdusek DC, Drohan WN The distribution of infectivity in blood components and plasma derivatives in experimental models of transmissible spongiform encephalopathy. Transfusion 1998; 38:810-6; PMID:9738619; http://dx.doi.org/10.1046/j.1537-2995.1998.38998408999.x
44. Brown P, Cervenakova L, McShane LM, Barber P., Rubenstein R, Drohan WN Further studies of blood infectivity in an experimental model of transmissible spongiform encephalopathy, with an explanation of why blood components do not transmit Creutzfeldt-Jakob disease in humans. Transfusion 1999; 39:1169-78; PMID:10604242; http://dx.doi.org/10.1046/j.1537-2995.1999.39111169.x
45. Cervenakova L, Yakovleva O, McKenzie C., Kolchinsky S, McShane L, Drohan WN, Brown P. Similar levels of infectivity in the blood of mice infected with human-derived vCJD and GSS strains of transmissible spongiform encephalopathy. Transfusion 2003; 43:1687-94; PMID:14641865; http://dx.doi.org/10.1046/j.0041-1132.2003.00586.x
46. Herzog C, Sales N, Etchegaray N., Charbonnier A, Freire S, Dormont D., Deslys JP, Lasmezas CI Tissue distribution of bovine spongiform encephalopathy agent in primates after intravenous or oral infection. Lancet 2004; 363:422-8; PMID:14962521; http://dx.doi.org/10.1016/S0140-6736(04)15487-1
47. Holada K, Vostal JG, Theisen PW, MacAuley C., Gregori L, Rohwer RG Scrapie infectivity in hamster blood is not associated with platelets. J Virol 2002; 76:4649-50; PMID:11932431; http://dx.doi.org/10.1128/JVI.76.9.4649-4650.2002
48. Miekka SI, Forng RY, Rohwer RG, MacAuley C., Stafford RE, Flack SL, MacPhee M, Kent RS, Drohan WN Inactivation of viral and prion pathogens by gamma-irradiation under conditions that maintain the integrity of human albumin. Vox Sang 2003; 84:36-44; PMID:12542732; http://dx.doi.org/10.1046/j.1423-0410.2003.00256.x
49. Gregori L, McCombie N, Palmer D., Birch P, Sowemimo-Coker SO, Giulivi A, Rohwer RG Effectiveness of leucoreduction for removal of infectivity of transmissible spongiform encephalopathies from blood. Lancet 2004; 364:529-31; PMID:15302197; http://dx.doi.org/10.1016/S0140-6736(04)16812-8
50. Houston F, Foster JD, Chong A, Hunter N., Bostock CJ Transmission of BSE by blood transfusion in sheep. Lancet 2000; 356:999-1000; PMID:11041 403; http://dx.doi.org/10.1016/S0140-6736(00)02719-7
51. Hunter N, Foster J, Chong A., McCutcheon S, Parnham D, Eaton S., MacKenzie C, Houston F. Transmission of prion diseases by blood transfusion. J Gen Virol 2002; 83:2897-905; PMID:12388826
52. Hunter N, Houston F. Can prion diseases be transmitted between individuals via blood transfusion: evidence from sheep experiments. Dev Biol (Basel) 2002; 108:93-8; PMID:12220147
53. McCutcheon S, Alejo Blanco AR, Houston EF, de Wolf C, Tan BC, Smith A, Groschup MH, Hunter N., Hornsey VS, MacGregor IR, et al All clinically-relevant blood components transmit prion disease following a single blood transfusion: a sheep model of vCJD. PLoS One 2011; 6:e23169; PMID:21858015; http://dx.doi.org/10.1371/journal.pone.0023169
54. Ironside JW, McCardle L, Horsburgh A., Lim Z, Head MW Pathological diagnosis of variant Creutzfeldt-Jakob disease. APMIS 2002; 110:79-87; PMID:12064259; http://dx.doi.org/10.1034/j.1600-0463.2002.100110.x
55. Foster JD, Parnham DW, Hunter N, Bruce M. Distribution of the prion protein in sheep terminally affected with BSE following experimental oral transmission. J Gen Virol 2001; 82:2319-26; PMID:11562525
56. Houston F, McCutcheon S, Goldmann W., Chong A, Foster J, Siso S., Gonzalez L, Jeffrey M, Hunter N. Prion diseases are efficiently transmitted by blood transfusion in sheep. Blood 2008; 112:4739-45; PMID:18647958; http://dx.doi.org/10.1182/blood-2008-04-152520
57. Andreoletti O, Litaise C, Simmons H., Corbiere F, Lugan S, Costes P., Schelcher F, Vilette D, Grassi J., Lacroux C. Highly efficient prion transmission by blood transfusion. PLoS Pathog 2012; 8:e1002782; PMID:22737075; http://dx.doi.org/10.1371/journal.ppat.1002782
58. Lacroux C, Vilette D, Fernández-Borges N, Litaise C, Lugan S, Morel N, Corbière F, Simon S, Simmons H, Costes P, et al. Prionemia and leukocyte-platelet-associated infectivity in sheep transmissible spongiform encephalopathy models. J Virol 2012; 86:2056-66; PMID:22156536; http://dx.doi.org/10.1128/JVI.06532-11
59. Mathiason CK, Hayes-Klug J, Hays SA, Powers J., Osborn DA, Dahmes SJ, Miller KV, Warren RJ, Mason GL, Telling GC, et al B cells and platelets harbor prion infectivity in the blood of deer infected with chronic wasting disease. J Virol 2010; 84:5097-107; PMID:20219916; http://dx.doi.org/10.1128/JVI.02169-09
60. Mathiason CK, Hays SA, Powers J, Hayes-Klug J, Langenberg J., Dahmes SJ, Osborn DA, Miller KV, Warren RJ, Mason GL, et al Infectious prions in preclinical deer and transmission of chronic wasting disease solely by environmental exposure. PLoS One 2009; 4:e5916; PMID:19529769; http://dx.doi.org/10.1371/journal.pone.0005916
61. Mathiason CK, Powers JG, Dahmes SJ, Osborn DA, Miller KV, Warren RJ, Mason GL, Hays SA, HayesKlug J, Seelig DM, et al Infectious prions in the saliva and blood of deer with chronic wasting disease. Science 2006; 314:133-6; PMID:17023660; http://dx.doi.org/10.1126/science.1132661
62. DH. vCJD: Further precautionary measures announced. http://webarchive.nationalarchives.gov.uk/C/www.dh.gov.uk/en/Publicationsandstatistics/Pressreleases/DH-4089689. 2004.
63. HPA Variant CJD and blood products. http://www.hpa.org.uk/webw/HPAweb&HPAwebStandard/HPAweb-C/1195733818681?pD1191942152861. 2004.
64. Llewelyn CA, Hewitt PE, Knight RS, Amar K., Cousens S, Mackenzie J, Will RG Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion. Lancet 2004; 363:417-21; PMID:14962520; http://dx.doi.org/10.1016/S0140-6736(04)15486-X
65. Wroe SJ, Pal S, Siddique D., Hyare H, Macfarlane R, Joiner S., Linehan JM, Brandner S, Wadsworth JD, Hewitt P, et al Clinical presentation and pre-mortem diagnosis of variant Creutzfeldt-Jakob disease associated with blood transfusion: a case report. Lancet 2006; 368:2061-7; PMID:17161728; http://dx.doi.org/10.1016/S0140-6736(06)69835-8
66. Hewitt PE, Llewelyn CA, Mackenzie J, Will RG Three reported cases of variant Creutzfeldt-Jakob disease transmission following transfusion of labile blood components. Vox Sang 2006; 91:348; PMID:17105 612; http://dx.doi.org/10.1111/j.1423-0410.2006.00837.x
67. Ironside JW. Variant Creutzfeldt-Jakob disease: an update. Folia Neuropathol 2012; 50:50-6; PMID:22505363
68. Ironside JW, Head MW, Peden A, Ward H. Asymptomatic vCJD infection detected at autopsy in a UK haemophilic patient. Haemophilia 2010; 16:29.
69. Millar CM, Connor N, Dolan G., Lee CA, Makris M, Wilde J, Winter M., Ironside JW, Gill N, Hill FG Risk reduction strategies for variant Creutzfeldt-Jakob disease transmission by UK plasma products and their impact on patients with inherited bleeding disorders. Haemophilia 2010; 16:305-15; PMID:20487442; http://dx.doi.org/10.1111/j.1365-2516.2010.02220.x
70. DH. vCJD risk assessment calculation for a patient with multiple routes of exposure. http://webarchive.nationalarchives.gov.uk/20130107105354/http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH-100357., 2009.
71. Douet JY, Zafar S, Perret-Liaudet A, Lacroux C, Lugan S, Aron N, Cassard H, Ponto C, Corbiere F, Torres JM, et al. Detection of infectivity in blood of persons with variant and sporadic Creutzfeldt-Jakob disease. Emerg Infect Dis 2014; 20:114-7; PMID:24377668; http://dx.doi.org/10.3201/eid2001.130353
72. Gregori L. A prototype assay to detect vCJD-infected blood. Lancet 2011; 377:444-6; PMID:21295340; http://dx.doi.org/10.1016/S0140-6736(11)60057-3
73. Cooper JK, Andrews N, Ladhani K., Bujaki E, Minor PD Evaluation of a test for its suitability in the diagnosis of variant Creutzfeldt-Jakob disease. Vox Sang 2013; 105:196-204; PMID:23772892; http://dx.doi.org/10.1111/vox.12037
74. Edgeworth JA, Farmer M, Sicilia A., Tavares P, Beck J, Campbell T., Lowe J, Mead S, Rudge P., Collinge J, et al. Detection of prion infection in variant Creutzfeldt-Jakob disease: a blood-based assay. Lancet 2011; 377:487-93; PMID:21295339; http://dx.doi.org/10.1016/S0140-6736(10)62308-2
75. Orrui CD, Wilham JM, Raymond LD, Kuhn F., Schroeder B, Raeber AJ, Caughey B. Prion disease blood test using immunoprecipitation and improved quaking-induced conversion. MBio 2011; 2:e00078-11; PMID:21558432; http://dx.doi.org/10.1128/mBio.00078-11
76. Cardone F, Sowemimo-Coker S, Abdel-Haq H, Sbriccoli M, Graziano S., Valanzano A, Berardi VA, Galeno R, Puopolo M., Pocchiari M. Assessment of prion reduction filters in decreasing infectivity of ultracentrifuged 263K scrapie-infected brain homogenates in "spiked" human blood and red blood cells. Transfusion 2014; 54:990-5 PMID:23915063; http://dx.doi.org/10.1111/trf.12369
77. Gregori L, Lambert BC, Gurgel PV, Gheorghiu L., Edwardson P, Lathrop JT, Macauley C, Carbonell RG, Burton SJ, Hammond D, et al Reduction of transmissible spongiform encephalopathy infectivity from human red blood cells with prion protein affinity ligands. Transfusion 2006; 46:1152-61; PMID:16836562; http://dx.doi.org/10.1111/j.1537-2995.2006.00865.x
78. Gregori LG, Lambert B, Rohwer R Ability of the macopharma prion capture (P-CAPTTM) filter to remove brain PrPres in leukoreduced human RBC. Vox Sang 2006; 91s3:37-320.
79. Lacroux C, Bougard D, Litaise C., Simmons H, Corbiere F, Dernis D., Tardivel R, Morel N, Simon S., Lugan S, et al. Impact of leucocyte depletion and prion reduction filters on TSE blood borne transmission. PLoS One 2012; 7:e42019; PMID:22860049; http://dx.doi.org/10.1371/journal.pone.0042019
80. Lescoutra N, Sumian C, Culeux A., Durand V, Deslys JP, Comoy EE Removal of Exogenous Prion Infectivity in Leucoreduced Red Blood Cells Unit by P-Capt (Tm) Prion Removal Filter. Vox Sang 2013; 105:197
81. Clewley JP, Kelly CM, Andrews N, Vogliqi K., Mallinson G, Kaisar M, Hilton DA, Ironside JW, Edwards P, McCardle LM, et al Prevalence of disease related prion protein in anonymous tonsil specimens in Britain: cross sectional opportunistic survey. BMJ 2009; 338:b1442; PMID:19460798; http://dx.doi.org/10.1136/bmj.b1442
82. de Marco MF, Linehan J, Gill ON, Clewley JP, Brandner S. Large-scale immunohistochemical examination for lymphoreticular prion protein in tonsil specimens collected in Britain. J Pathol 2010; 222:380-7; PMID:20922767; http://dx.doi.org/10.1002/path.2767
83. Hilton DA, Ghani AC, Conyers L, Edwards P., McCardle L, Ritchie D, Penney M., Hegazy D, Ironside JW Prevalence of lymphoreticular prion protein accumulation in UK tissue samples. J Pathol 2004; 203:733-9; PMID:15221931; http://dx.doi.org/10.1002/path.1580
84. HPA. Creutzfeldt-Jakob disease (CJD) biannual update. http://www.hpa.org.uk/hpr/archives/2012/hpr0612.pdf, 2012.
85. Bruce ME, McConnell I, Will RG, Ironside JW Detection of variant Creutzfeldt-Jakob disease infectivity in extraneural tissues. Lancet 2001; 358:208-9; PMID:11476840; http://dx.doi.org/10.1016/S0140-6736(01)05411-3
86. Hilton DA, Ghani AC, Conyers L, Edwards P., McCardle L, Penney M, Ritchie D., Ironside JW Accumulation of prion protein in tonsil and appendix: review of tissue samples. BMJ 2002; 325:633-4; PMID:12242174; http://dx.doi.org/10.1136/bmj.325.7365.633
87. Frosh A, Smith LC, Jackson CJ, Linehan JM, Brandner S, Wadsworth JD, Collinge J. Analysis of 2000 consecutive UK tonsillectomy specimens for disease-related prion protein. Lancet 2004; 364:1260-2; PMID:15464187; http://dx.doi.org/10.1016/S0140-6736(04)17143-2
88. Parliamentary Select Committee on Science and Technology. MPs launch inquiry on blood, tissue and organs screening following vCJD fears. 2013. http://www.parliament.uk/business/committees/committees-a-z/commons-select/science-and-technology-committee/news/131203-blood-tissue-and-organ-screening-tor/.
89. Zeidler M, Johnstone EC, Bamber RW, Dickens CM, Fisher CJ, Francis AF, Goldbeck R, Higgo R., Johnson-Sabine EC, Lodge GJ, et al New variant Creutzfeldt-Jakob disease: psychiatric features. Lancet 1997; 350:908-10; PMID:9314868; http://dx.doi.org/10.1016/S0140-6736(97)03148-6
90. Zeidler M, Stewart GE, Barraclough CR, Bateman DE, Bates D, Burn DJ, Colchester AC, Durward W., Fletcher NA, Hawkins SA, et al New variant Creutzfeldt-Jakob disease: neurological features and diagnostic tests. Lancet 1997; 350:903-7; PMID:9314867; http://dx.doi.org/10.1016/S0140-6736(97)07472-2
91. Heath CA, Cooper SA, Murray K, Lowman A., Henry C, MacLeod MA, Stewart G, Zeidler M., McKenzie JM, Knight RS, et al Diagnosing variant CreutzfeldtJakob disease: a retrospective analysis of the first 150 cases in the UK. J Neurol Neurosurg Psychiatry 2011; 82:646-51; PMID:21172857; http://dx.doi.org/10.1136/jnnp.2010.232264
92. Binelli S, Agazzi P, Giaccone G., Will RG, Bugiani O, Franceschetti S, Tagliavini F. Periodic electroencephalogram complexes in a patient with variant Creutzfeldt-Jakob disease. Ann Neurol 2006; 59:423-7; PMID:16437565; http://dx.doi.org/10.1002/ana.20768
93. Green AJ, Thompson EJ, Stewart GE, Zeidler M., McKenzie JM, MacLeod MA, Ironside JW, Will RG, Knight RS Use of 14-3-3 and other brain-specific proteins in CSF in the diagnosis of variant Creutzfeldt-Jakob disease. J Neurol Neurosurg Psychiatry 2001; 70:744-8; PMID:11385008; http://dx.doi.org/10.1136/jnnp.70.6.744
94. Zeidler M, Sellar RJ, Collie DA, Knight R., Stewart G, Macleod MA, Ironside JW, Cousens S., Colchester AC, Hadley DM, et al The pulvinar sign on magnetic resonance imaging in variant Creutzfeldt-Jakob disease. Lancet 2000; 355:1412-8; PMID:10791525; http://dx.doi.org/10.1016/S0140-6736(00)02140-1
95. Hill AF, Butterworth RJ, Joiner S, Jackson G., Rossor MN, Thomas DJ, Frosh A, Tolley N., Bell JE, Spencer M, et al Investigation of variant Creutzfeldt-Jakob disease and other human prion diseases with tonsil biopsy samples. Lancet 1999; 353:183-9; PMID:9923873; http://dx.doi.org/10.1016/S0140-6736(98)12075-5
96. Mead S, Wadsworth JD, Porter MC, Linehan JM, Pietkiewicz W, Jackson GS, Brandner S, Collinge J. Variant Creutzfeldt-Jakob disease with extremely low lymphoreticular deposition of prion protein. JAMA Neurol 2014; 71:340-3; PMID:24445428; http://dx.doi.org/10.1001/jamaneurol.2013.5378
97. Will RG, Zeidler M, Stewart GE, Macleod MA, Ironside JW, Cousens SN, Mackenzie J, Estibeiro K., Green AJ, Knight RS Diagnosis of new variant Creutzfeldt-Jakob disease. Ann Neurol 2000; 47:575-82; PMID:10805327; http://dx.doi.org/10.1002/1531-8249(200005)47:5<575::AID-ANA4>3.0.CO;2-W
98. Heath CA, Cooper SA, Murray K, Lowman A., Henry C, MacLeod MA, Stewart GE, Zeidler M., MacKenzie JM, Ironside JW, et al Validation of diagnostic criteria for variant Creutzfeldt-Jakob disease. Ann Neurol 2010; 67:761-70; PMID:20517937
99. Häik S., Marcon G, Mallet A., Tettamanti M, Welaratne A, Giaccone G., Azimi S, Pietrini V, Fabreguettes JR, Imperiale D., et al. Doxycycline in CreutzfeldtJakob disease: a phase 2, randomised, double-blind, placebo-controlled trial. Lancet Neurol 2014; 13:150-8; PMID:24411709; http://dx.doi.org/10.1016/S1474-4422(13)70307-7
100. Collinge J, Gorham M, Hudson F., Kennedy A, Keogh G, Pal S., Rossor M, Rudge P, Siddique D., Spyer M, et al. Safety and efficacy of quinacrine in human prion disease (PRION-1 study): a patient-preference trial. Lancet Neurol 2009; 8:334-44; PMID:19278902; http://dx.doi.org/10.1016/S1474-4422(09)70049-3
101. Doh-ura K., Ishikawa K, Murakami-Kubo I, Sasaki K., Mohri S, Race R, Iwaki T. Treatment of transmissible spongiform encephalopathy by intraventricular drug infusion in animal models. J Virol 2004; 78:4999-5006; PMID:15113880; http://dx.doi.org/10.1128/JVI.78.10.4999-5006.2004
102. Parry A, Baker I, Stacey R., Wimalaratna S. Long term survival in a patient with variant Creutzfeldt-Jakob disease treated with intraventricular pentosan polysulphate. J Neurol Neurosurg Psychiatry 2007; 78:733-4; PMID:17314188; http://dx.doi.org/10.1136/jnnp.2006.104505
103. Todd NV, Morrow J, Doh-ura K, Dealler S., O'Hare S, Farling P, Duddy M., Rainov NG Cerebroventricular infusion of pentosan polysulphate in human variant Creutzfeldt-Jakob disease. J Infect 2005; 50:394-6; PMID:15907546; http://dx.doi.org/10.1016/j.jinf.2004.07.015
104. Bone I, Belton L, Walker AS, Darbyshire J. Intraventricular pentosan polysulphate in human prion diseases: an observational study in the UK. Eur J Neurol 2008; 15:458-64; PMID:18355301; http://dx.doi.org/10.1111/j.1468-1331.2008.02108.x
105. Newman PK, Todd NV, Scoones D, Mead S., Knight RS, Will RG, Ironside JW Postmortem findings in a case of variant Creutzfeldt-Jakob disease treated with intraventricular pentosan polysulfate. J Neurol Neurosurg Psychiatry 2014; (Forthcoming); PMID:24554103; http://dx.doi.org/10.1136/jnnp-2013-305590
106. Bishop MT, Will RG, Manson JC Defining sporadic Creutzfeldt-Jakob disease strains and their transmission properties. Proc Natl Acad Sci U S A 2010; 107:12005-10; PMID:20547859; http://dx.doi.org/10.1073/pnas.1004688107
107. Moda F, Suardi S, Di Fede G, Indaco A, Limido L., Vimercati C, Ruggerone M, Campagnani I., Langeveld J, Terruzzi A, et al. MM2-thalamic Creutzfeldt-Jakob disease: neuropathological, biochemical and transmission studies identify a distinctive prion strain. Brain Pathol 2012; 22:662-9; PMID:22288561; http://dx.doi.org/10.1111/j.1750-3639.2012.00572.x
108. Barron RM, Campbell SL, King D, Bellon A., Chapman KE, Williamson RA, Manson JC High titers of transmissible spongiform encephalopathy infectivity associated with extremely low levels of PrPSc in vivo. J Biol Chem 2007; 282:35878-86; PMID:17923484; http://dx.doi.org/10.1074/jbc.M704329200
109. Piccardo P, Manson JC, King D, Ghetti B., Barron RM Accumulation of prion protein in the brain that is not associated with transmissible disease. Proc Natl Acad Sci U S A 2007; 104:4712-7; PMID:17360589; http://dx.doi.org/10.1073/pnas.0609241104
110. Head MW, Yull HM, Ritchie DL, Langeveld JP, Fletcher NA, Knight RS, Ironside JW Variably prote-ase-sensitive prionopathy in the UK: a retrospective review 1991-2008. Brain 2013; 136:1102-15; PMID:23550113; http://dx.doi.org/10.1093/brain/aws366
111. Wilson R, Plinston C, Hunter N., Casalone C, Corona C, Tagliavini F., Suardi S, Ruggerone M, Moda F., Graziano S, et al. Chronic wasting disease and atypical forms of bovine spongiform encephalopathy and scrapie are not transmissible to mice expressing wild-type levels of human prion protein. J Gen Virol 2012; 93:1624-9; PMID:22495232; http://dx.doi.org/10.1099/vir.0.042507-0
112. Kong Q, Zheng M, Casalone C., Qing L, Huang S, Chakraborty B., Wang P, Chen F, Cali I., Corona C, et al. Evaluation of the human transmission risk of an atypical bovine spongiform encephalopathy prion strain. J Virol 2008; 82:3697-701; PMID:18234793; http://dx.doi.org/10.1128/JVI.02561-07
113. Beringue V, Herzog L, Reine F., Le Dur A, Casalone C, Vilotte JL, Laude H. Transmission of atypical bovine prions to mice transgenic for human prion protein. Emerg Infect Dis 2008; 14:1898-901; PMID:19046515; http://dx.doi.org/10.3201/eid1412.080941
114. Sandberg MK, Al-Doujaily H, Sigurdson CJ, Glatzel M., O'Malley C, Powell C, Asante EA, Linehan JM, Brandner S, Wadsworth JD, et al Chronic wasting disease prions are not transmissible to transgenic mice overexpressing human prion protein. J Gen Virol 2010; 91:2651-7; PMID:20610667; http://dx.doi.org/10.1099/vir.0.024380-0
115. Tamgüney G., Giles K, Bouzamondo-Bernstein E, Bosque PJ, Miller MW, Safar J, DeArmond SJ, Prusiner SB Transmission of elk and deer prions to transgenic mice. J Virol 2006; 80:9104-14; PMID:16940522; http://dx.doi.org/10.1128/JVI.00098-06
116. Barria MA, Balachandran A, Morita M., Kitamoto T, Barron R, Manson J., Knight R, Ironside JW, Head MW Molecular barriers to zoonotic transmission of prions. Emerg Infect Dis 2014; 20:88-97; PMID:24377702; http://dx.doi.org/10.3201/eid2001.130858
117. Gambetti P, Dong Z, Yuan J., Xiao X, Zheng M, Alshekhlee A., Castellani R, Cohen M, Barria MA, Gonzalez-Romero D, et al. A novel human disease with abnormal prion protein sensitive to protease. Ann Neurol 2008; 63:697-708; PMID:18571782; http://dx.doi.org/10.1002/ana.21420
118. Head MW, Knight R, Zeidler M., Yull H, Barlow A, Ironside JW A case of protease sensitive prionopathy in a patient in the UK. Neuropathol Appl Neurobiol 2009; 35:628-32; PMID:19671081; http://dx.doi.org/10.1111/j.1365-2990.2009.01040.x